TOLPERISONE 150mg. IP

A centrally acting muscle relaxant for the symptomatic treatment of spasticity and muscle spasm. (Bhupesh Dewan, 2011) Stabilizes the nerve membrane and inhibits pathologic mono- and polysynaptic reflex activity. (Dejun Luo, 2017) An effective and well-tolerated option for the treatment of patients with skeletal muscle spasms associated with pain. (Rajeev Rao, 2012) Superior to baclofen in terms of efficacy and safety in adult patients with spasticity of spinal origin. (David Cancel MD, 2019) Significantly improves muscle cramps, heaviness of the legs, startle attacks, flexor spasms, and repeated falls in patients with neurolathyrism. (A Melka, 1997) Ameliorates the walking ability and speed of walking in the neurolathyrism population. (A Melka, 1997) Relieves spasticities of neurological origin and muscle spasms associated with painful locomotor diseases. (Rajeev Rao A. P., 2012) Provides better clinical response rates and symptom control over Thiocolchicoside 8 mg in patients with acute low back pain with spinal muscle spasm. (Rajeev Rao A. P., 2012) A safe & effective alternative to skeletal muscle relaxants in the management of acute painful spasm conditions associated with degenerative or inflammatory diseases of the musculoskeletal system. (Ram Prabhoo, 2011) More effective muscle relaxant in providing improvement in daily activities as compared to baclofen in spasticity caused by spinal cord injury. (Saurabh Agarwal, 2017)